Amgen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. 

CEO
Robert A. Bradway
CEORobert A. Bradway
Employees
31,500
Employees31,500
Headquarters
Thousand Oaks, California
HeadquartersThousand Oaks, California
Founded
1980
Founded1980
Employees
31,500
Employees31,500

AMGN Key Statistics

Market cap
187.54B
Market cap187.54B
Price-Earnings ratio
24.60
Price-Earnings ratio24.60
Dividend yield
2.76%
Dividend yield2.76%
Average volume
2.95M
Average volume2.95M
High today
$351.25
High today$351.25
Low today
$344.95
Low today$344.95
Open price
$348.01
Open price$348.01
Volume
9.17M
Volume9.17M
52 Week high
$391.29
52 Week high$391.29
52 Week low
$261.43
52 Week low$261.43

Stock Snapshot

Amgen(AMGN) stock is priced at $348.00, giving the company a market capitalization of 187.54B. It carries a P/E multiple of 24.60 and pays a dividend yield of 2.8%.

As of 2026-03-21, Amgen(AMGN) stock has fluctuated between $344.95 and $351.25. The current price stands at $348.00, placing the stock +0.9% above today's low and -0.9% off the high.

Amgen(AMGN) shares are trading with a volume of 9.17M, against a daily average of 2.95M.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

During the past year, Amgen(AMGN) stock moved between $261.43 at its lowest and $391.29 at its peak.

AMGN News

Simply Wall St 1d
Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation

Amgen and Kyowa Kirin have discontinued all clinical trials of rocatinlimab after newly identified safety risks, including malignancy cases. The decision remov...

Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Risks And Valuation
TipRanks 2d
Amgen Expands Oncology Pipeline With New Phase 1 AMG 436 Study in MSI-H/dMMR Tumors

Amgen Inc (AMGN) announced an update on their ongoing clinical study. The Phase 1/1b study “A Phase 1/1b Study Evaluating the Safety, Tolerability, and Pharmac...

TipRanks 2d
Amgen price target raised to $390 from $375 at Wells Fargo

Wells Fargo raised the firm’s price target on Amgen to $390 from $375 and keeps an Equal Weight rating on the shares. The firm thinks new drugs and mechanisms s...

Analyst ratings

53%

of 38 ratings
Buy
39.5%
Hold
52.6%
Sell
7.9%

More AMGN News

Benzinga 5d
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report

This move will augment the total number of discounted prescription medications available on the platform to 54, from five different pharmaceutical companies, ac...

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Simply Wall St 5d
Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus

Amgen has partnered with the government run TrumpRx platform to offer deep discounts on key brand name drugs. The agreement covers major products such as Amjev...

Amgen TrumpRx Discounts Put Drug Pricing And Growth Story In Focus
Simply Wall St 6d
How Investors May Respond To Amgen Dividend, Obesity Drug Focus, And Cardiovascular Trial Updates

In early March 2026, Amgen announced a US$2.52 per-share second-quarter dividend payable on June 5, 2026, and presented its growth and pipeline outlook at the L...

How Investors May Respond To Amgen Dividend, Obesity Drug Focus, And Cardiovascular Trial Updates
Seeking Alpha 7d
Amgen and GSK said to be adding products on TrumpRx

Amgen (AMGN) and GSK (GSK) will be the latest drugmakers to sell their medicines on TrumpRx as the government-run direct-to-consumer platform for pharmaceutical...

Amgen and GSK said to be adding products on TrumpRx

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.